收稿日期: 2022-02-24
录用日期: 2022-07-12
网络出版日期: 2022-09-04
基金资助
国家自然科学基金(82070123)
Levels of adiponectin in the peripheral blood of patients with immune thrombocytopenia and its effect on the differentiation of megakaryocyte cell line
Received date: 2022-02-24
Accepted date: 2022-07-12
Online published: 2022-09-04
Supported by
National Natural Science Foundation of China(82070123)
目的·探究脂联素在免疫性血小板减少症(immune thrombocytopenia,ITP)患者外周血血浆中的水平,以及其对巨核细胞分化、成熟的影响。方法·2021年1月至2022年2月,收集苏州大学附属第一医院血液科46例ITP患者及体检中心30名性别、年龄相对应的健康对照者外周血标本,使用人脂联素酶联免疫吸附测定(enzyme-linked immunosorbent assay,ELISA)试剂盒检测ITP患者与健康对照(HC)组的血浆脂联素水平,并分析ITP患者脂联素水平与其身体质量指数(body mass index,BMI)的相关性。在细胞实验方面,利用实时荧光定量PCR(RT-qPCR)、Western blotting分别在mRNA水平和蛋白水平上研究脂联素受体(ADIPOR1、ADIPOR2)在髓系细胞株K562,巨核细胞系细胞株MEG-01、Dami中的表达。用豆蔻酰佛波醇乙酯(phorbol 12-myristate 13-acetate,PMA)诱导K562细胞株分化,诱导MEG-01及Dami细胞株成熟,同时给予不同浓度的脂联素受体激动剂AdipoRon处理,采用流式细胞术检测CD41+细胞百分比、CD41平均荧光强度(mean fluoresence intensity,MFI)、多倍体细胞(≥4N)比例。结果·与HC组比较,ITP患者血浆脂联素水平显著升高(P=0.000),且与患者BMI无明显相关性(P=0.621)。RT-qPCR和Western blotting均发现K562、MEG-01及Dami细胞株表达ADIPOR1和ADIPOR2。10 μmol/L、20 μmol/L AdipoRon与PMA共同培养K562细胞株72 h后CD41+细胞比例显著低于PMA+DMSO组(均P=0.000)。20 μmol/L AdipoRon与PMA共同培养MEG-01细胞株72 h后CD41-MFI(P=0.047)和多倍体细胞比例(P=0.003)均显著高于PMA+DMSO组;但在Dami细胞株中,20 μmol/L AdipoRon与PMA处理后未发现两者显著升高。结论·ITP患者外周血血浆脂联素水平升高;人髓系细胞株K562、巨核细胞系细胞株MEG-01及Dami均表达脂联素受体ADIPOR1和ADIPOR2;脂联素受体激动剂可以在体外抑制巨核细胞分化,但其对巨核细胞成熟的影响尚不明确。
李昕雨 , 左斌 , 王文 , 钮晓音 , 翁震 , 何杨 . 脂联素在免疫性血小板减少症患者外周血中的水平及其对巨核细胞系分化的作用[J]. 上海交通大学学报(医学版), 2022 , 42(7) : 866 -874 . DOI: 10.3969/j.issn.1674-8115.2022.07.004
·To explore the level of adiponectin in the peripheral blood plasma of patients with immune thrombocytopenia (ITP) and its effect on the differentiation and maturation of megakaryocytes.
·From January 2021 to February 2022, the peripheral blood samples were collected from 46 ITP patients in the Department of Hematology, The First Affiliated Hospital of Soochow University and 30 healthy controls with corresponding gender and age in the physical examination center. The plasma adiponectin levels in the ITP patients and healthy control (HC) group were detected by using human adiponectin enzyme-linked immunosorbent assay (ELISA) kits. And the correlation between adiponectin level and body mass index (BMI) in the ITP patients was analyzed. In terms of cell experiments, real-time quantitative PCR (RT-qPCR) and Western blotting were used to study the expression of adiponectin receptors (ADIPOR1 and ADIPOR2) in the myeloid cell line K562, and the megakaryocyte cell lines MEG-01 and Dami at mRNA and protein levels, respectively. The differentiation of K562 cell line and the maturation of MEG-01 and Dami cell lines were induced by phorbol 12-myristate 13-acetate (PMA). At the same time, the cells were treated with different concentrations of adiponectin receptor agonist AdipoRon. Flow cytometry was used to detect the percentage of CD41+ cells, the mean fluorescence intensity (MFI) of CD41, and the proportion of polyploid cells (≥4N).
·Compared with the HC group, the plasma adiponectin level of the ITP patients significantly increased (P=0.000), and there was no significant correlation between the adiponectin level and the BMI of the patients (P=0.621). RT-qPCR and Western blotting showed that ADIPOR1 and ADIPOR2 were expressed in K562, MEG-01 and Dami cell lines. The proportion of CD41+ cells in the K562 cell line co-cultured with 10 μmol/L or 20 μmol/L AdipoRon and PMA for 72 h were significantly lower than those in the PMA+DMSO group (P=0.000). The CD41-MFI (P=0.047) and the proportion of polyploid cells (P=0.003) in the MEG-01 cell line co-cultured with 20 μmol/L AdipoRon and PMA for 72 h were significantly higher than those in the PMA+DMSO group; however, in the Dami cell line, no significant increases of both were found after the treatment of 20 μmol/L AdipoRon and PMA.
·The adiponectin level is elevated in the peripheral blood plasma of ITP patients. Human myeloid cell line K562, and megakaryocyte cell lines MEG-01 and Dami all express adiponectin receptors ADIPOR1 and ADIPOR2. Adiponectin receptor agonists can inhibit megakaryocyte differentiation in vitro, but its effect on megakaryocyte maturation is uncertain.
1 | RODEGHIERO F, STASI R, GERNSHEIMER T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group[J]. Blood, 2009, 113(11): 2386-2393. |
2 | ZUFFEREY A, KAPUR R, SEMPLE J W. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)[J]. J Clin Med, 2017, 6(2): 16. |
3 | GHALLOUSSI D, DHENGE A, BERGMEIER W. New insights into cytoskeletal remodeling during platelet production[J]. J Thromb Haemost, 2019, 17(9): 1430-1439. |
4 | LI Q W, WU Y S, KANG N. Marrow adipose tissue: its origin, function, and regulation in bone remodeling and regeneration[J]. Stem Cells Int, 2018, 2018: 7098456. |
5 | YANAI H, YOSHIDA H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives[J]. Int J Mol Sci, 2019, 20(5): 1190. |
6 | DIMASCIO L, VOERMANS C, UQOEZWA M, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor[J]. J Immunol, 2007, 178(6): 3511-3520. |
7 | NEUNERT C, TERRELL D R, ARNOLD D M, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia[J]. Blood Adv, 2019, 3(23): 3829-3866. |
8 | 中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J]. 中华血液学杂志, 2020, 41(8): 617-623. |
8 | Thrombosis and Hemostasis Group, Chinese Society of Hematology. Chinese guidelines for the diagnosis and treatment of adult primary immune thrombocytopenia (2020 edition)[J]. Chin J Hematol, 2020, 41(8): 617-623. |
9 | ALITALO R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts[J]. Leuk Res, 1990, 14(6): 501-514. |
10 | KONG X Z, YIN R H, NING H M, et al. Effects of THAP11 on erythroid differentiation and megakaryocytic differentiation of K562 cells[J]. PLoS One, 2014, 9(3): e91557. |
11 | QU M Y, ZOU X J, FANG F, et al. Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p[J]. Nat Commun, 2020, 11(1): 4964. |
12 | ISAKARI Y, SOGO S, ISHIDA T, et al. Gene expression analysis during platelet-like particle production in phorbol myristate acetate-treated MEG-01 cells[J]. Biol Pharm Bull, 2009, 32(3): 354-358. |
13 | MA D C, YU H Y, LIN D, et al. S6K1 is involved in polyploidization through its phosphorylation at Thr421/Ser424[J]. J Cell Physiol, 2009, 219(1): 31-44. |
14 | MIYASHITA N, ONOZAWA M, YOKOYAMA S, et al. Anagrelide modulates proplatelet formation resulting in decreased number and increased size of platelets[J]. HemaSphere, 2019, 3(4): e268. |
15 | WILHIDE C C, VAN DANG C, DIPERSIO J, et al. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest[J]. Blood, 1995, 86(1): 294-304. |
16 | NIELSEN M B, ?OLAK Y, BENN M, et al. Causal relationship between plasma adiponectin and body mass index: one- and two-sample bidirectional Mendelian randomization analyses in 460 397 individuals[J]. Clin Chem, 2020, 66(12): 1548-1557. |
17 | TAKAHATA C, MIYOSHI Y, IRAHARA N, et al. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells[J]. Cancer Lett, 2007, 250(2): 229-236. |
18 | BRIGHTON T A, EVANS S, CASTALDI P A, et al. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias[J]. Blood, 1996, 88(1): 194-201. |
19 | MCMILLAN R, WANG L, TANI P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)[J]. J Thromb Haemost, 2003, 1(3): 485-491. |
20 | WARNER M N, MOORE J C, WARKENTIN T E, et al. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura[J]. Br J Haematol, 1999, 104(3): 442-447. |
21 | CHEN S L, HU M J, SHEN M Q, et al. IGF-1 facilitates thrombopoiesis primarily through Akt activation[J]. Blood, 2018, 132(2): 210-222. |
22 | GAINSFORD T, ROBERTS A W, KIMURA S, et al. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production[J]. Blood, 1998, 91(8): 2745-2752. |
23 | KUO S M, HALPERN M M. Lack of association between body mass index and plasma adiponectin levels in healthy adults[J]. Int J Obes (Lond), 2011, 35(12): 1487-1494. |
24 | CHANG M, NAKAGAWA P A, WILLIAMS S A, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro[J]. Blood, 2003, 102(3): 887-895. |
25 | MCMILLAN R, WANG L, TOMER A, et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP[J]. Blood, 2004, 103(4): 1364-1369. |
26 | YANG L, WANG L, ZHAO C H, et al. Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia[J]. Blood, 2010, 116(20): 4307-4316. |
/
〈 |
|
〉 |